Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company

Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and enforcement of federal antitrust laws, is investigating potential wrongdoing at K-V Pharmaceutical Company (“K-V” or the “Company”) (NYSE: KV-A) (NYSE: KV-B). Faruqi & Faruqi, LLP seeks to determine whether certain officers and directors at K-V violated federal securities laws in connection with statements made to the Company's shareholders.

Request more information now by clicking here: www.faruqilaw.com/KV.

The investigation focuses on whether certain individuals violated federal securities laws by, among other things, failing to disclose that: (1) the Company had inaccurately claimed that the Food and Drug Administration (the “FDA”) was granting K-V the exclusive distribution rights over “Makena,” a drug used to prevent miscarriages; (2) the FDA would not be enforcing K-V’s rights by preventing the Company’s competitors from distributing generic formulations of the drug; and (3) the drug’s $1,500 price would reduce the availability of Makena to low-income and other at-risk groups.

On March 30, 2011, the FDA revealed that it did not intend to take enforcement action against K-V’s competitors for distributing generic versions of K-V’s Makena.

Take Action

If you purchased K-V securities between February 14, 2011 and April 4, 2011 and you would like to discuss your legal rights, visit www.faruqilaw.com/KV. You can also contact us by calling Anthony Vozzolo or Richard W. Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to avozzolo@faruqilaw.com or rgonnello@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding K-V's conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.

About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP is a national law firm, representing investors, consumers and companies in the prosecution of claims under state corporate and consumer laws and the federal securities and antitrust laws. The lawyers at Faruqi & Faruqi, LLP have demonstrated a clear commitment to championing the rights of shareholders and consumers nationwide.

Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

K V Pharma CL A (NYSE:KVA)
過去株価チャート
から 5 2024 まで 6 2024